HU

Hutchmed (China) Limited

Overview

Corporate Details

ISIN(s):
KYG4672N1198 (+1 more)
LEI:
2138006X34YDQ6OBYE79
Country:
Hong Kong
Address:
LEVEL 18, THE METROPOLIS TOWER, KOWLOON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Hutchmed (China) Limited. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 08:00
Board/Management Information
Directorate Change
English 17.9 KB
2025-08-20 08:00
Regulatory News Service
HUTCHMED Completes Enrollment of Phase III Trial
English 29.1 KB
2025-08-07 13:00
Earnings Release
2025 Interim Results
English 141.5 KB
2025-07-03 10:30
Report Publication Announcement
HUTCHMED to Announce 2025 Half-Year Results
English 12.1 KB
2025-06-30 10:30
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 12.4 KB
2025-06-30 10:30
Remuneration Information
Blocklisting Six Monthly Return
English 25.1 KB
2025-06-30 10:30
Regulatory News Service
China Approval based on Phase III SACHI Trial
English 29.8 KB

Automate Your Workflow. Get a real-time feed of all Hutchmed (China) Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Hutchmed (China) Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Alkaloid AD Logo
Manufacturing pharmaceuticals, cosmetics, and botanicals for consumer and healthcare markets.
North Macedonia ALK
ALLERGY THERAPEUTICS PLC Logo
Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.
United Kingdom AGY
Israel KVSR
Almirall S.A. Logo
A global biopharmaceutical company developing innovative medical solutions for skin health.
Spain ALM
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg ALVO
Amphastar Pharmaceuticals Inc. Logo United States of America AMPH
Develops approved cannabinoid medicines for complex, chronic conditions like pain and epilepsy.
United Kingdom N/A
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye ANGEN
AnGes, Inc. Logo Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR